DeZhan Health
Overview
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, and hydroxyurea tablets and colchicine tablet. It also involved in the provision of b
Employees1067
Market Cap$6.5B
Revenue$396.2M
Listed OnShenzhen Stock Exchange
Ticker000813
CEOMr. Wei Liu
HeadquartersBeijing